期刊文献+

重组人胰岛素在毕赤氏酵母中的分泌表达 被引量:2

Secretory Expression of Recombinant Human Insulin in the Pichia Pastoris
原文传递
导出
摘要 利用套叠PCR技术合成重组人胰岛素基因,并在A链和B链之间加入Kex2酶切位点。将合成的重组人胰岛素基因以正确的阅读框插入到组成型分泌表达载体pGAPZα-A的α-factor信号肽序列的下游,构建成pGAPZα-A/Insulin重组分泌表达载体。表达载体用BlnI线性化处理后电击转化毕赤酵母GS115感受态细胞,构建成分泌型表达Insulin的工程菌。SDS-PAGE和Native-PAGE的分析表明:蛋白在分泌表达过程中,加入Insu-lin的A链(2.4k)和B链(3.4k)之间的Kex2酶切位点发挥了作用,Kex2蛋白酶将A链和B链切开,在α-factor信号肽的作用下通过分泌途径将A链和B链分泌到胞外,同时A链和B链又以二硫键形成了高级结构。Western Blot结果表明:重组蛋白能够与鼠抗人Insulin抗体发生特异性反应,具有与天然Insulin相同的免疫原性。 The recombinant human insulin gene was connected by overlap extension PCR. The Kex2 cleavage site was inserted between A chain and B chain. Then, the recombinant human insulin gene was ligated into pGAPZα-A vector. In order to generate a secreting expression vector pGAPZα-A/Insulin, the open reading frame of the gene was ligated with the vector of pGAPZα-A, on the downstream encoding the α-factor signal sequence. After being linearized by Bin I, the recombinant vector was transformed into competent cells of Pichia pastoris GS115 by electroporation. The analysis of SDS-PAGE and Native-PAGE showed that A chain and B chain were cleaved by Kex2 proteinase during the secretory expression of insulin. The analysis of Western blot indicated that recombinant human insulin had the antigenicity to rat anti-human insulin monoelonal antibody, which had the same immunogenicity as natural human insulin.
出处 《药物生物技术》 CAS CSCD 2009年第2期108-112,共5页 Pharmaceutical Biotechnology
关键词 重组人胰岛素 毕赤酵母 分泌表达 Recombinant human insulin, Pichia pastoris, Secretory expression
  • 相关文献

参考文献14

  • 1Siegel R, Brierley RA Methylotrophic yeast Pichia pastoris produced in high-cell density fermentations with high cell yields as vehicle for recombinant protein production [J]. Biotechnology Bioengineering, 1989, 34(3) : 403.
  • 2Sreekrishna K, Brankamp RG, Kropp KE, et al. Strategies for optimal synethesis and secretion of heterologous proteins in the methylotrophic yeast Pichia pastoris [J]. Gene, 1997, 190(1):55.
  • 3曹佐武.有效分离1kDa小肽的Tricine-SDS-PAGE方法[J].中国生物工程杂志,2004,24(1):74-76. 被引量:78
  • 4J.萨姆布鲁克D.W.拉塞尔.分子克隆实验指南[M].第三版,北京:科学出版社,2002,1682.
  • 5汪家政 范明.蛋白质技术手册[M].北京:科学出版社,2002.77-97.
  • 6Burnett J P. Commercial production of recombinant DNA-derived products [A]. In: Masayori I. (ed), Experimentalmanipulation of gene expression [C]. New york: AcademicPress, 1983, 259.
  • 7Morihara K, Muneyuki R, Oka T. Use of immobilized achromobacter protease I for semisynthesis of human insulin [J]. Methods Enzymol, 1987,136:162.
  • 8Ueno Y, Morihara K. Use of immobilized trypin for semisynthesis of human insulin [J]. Biotechnology Bioengineering, 1989,33:126.
  • 9王燕,梁镇和,张友尚,崔大敷,冯佑民.人胰岛素在甲醇酵母Pichiapa storis中的分泌表达[J].生物化学与生物物理学报,1999,31(5):587-589. 被引量:19
  • 10郭永志,沈孝宙.人胰岛素原在甲醇酵母(Pichia pastoris)中的高效表达[J].生物工程进展,1999,19(6):64-67. 被引量:14

二级参考文献8

共引文献250

同被引文献26

  • 1张怡,谭树华.IMPACT-TWIN蛋白纯化系统的机制及其应用[J].生物技术世界,2013,10(10):8-8. 被引量:1
  • 2马宝全,康伟,晏俊开,Vasily M Gelfanov,David L Smiley,Richard D DiMarchi.TyrB^(26)位点改变的人类胰岛素类似物的化学合成与体外活性[J].中国生物工程杂志,2007,27(7):40-44. 被引量:1
  • 3Howay DC, Bowsher PR, Brunelle RL, et al. [ Lys ( B28 ) , pro ( B29 ) ] human insulin a rapidly absorbed analogue of human insulin [ J ]. Phamacokinet phamaoodyn ,2003,30 ( 3 ) : 221.
  • 4Edelman SV, Morello CM. Strategies for insulin therapy in type 2 diabete[ J]. South Med J,2005,98 (3) :363 -71.
  • 5Jermendy G. Evidence based therapy with insulin in diabetic patients [ J ]. Orv Hetil, 2005,146 ( 8 ) :341 - 52.
  • 6Murase Y,Yagi K,SugiharaM ,et al. Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes[ J]. Intern Med,2004,43:779 - 86.
  • 7Lind M,Fahlen M, Happich M,et al. The effect of insulin lispro on glycemic control in a large patient cohort[ J]. Diabetes Technol Ther,2009,11 (1) :51 -6.
  • 8Von Mach Ma, Brinkman C, Hansen T, et al. Differences in phamacokinetics and phamlacodynamics of insulin lispro and aspart in healthy volunteers [J ]. Expclin Endoerinol Diabetes, 2002, 110 : 416 -9.
  • 9Poulsen C, Langkjaer L, Worsoe C. Precipitation of insulin products used for continuous subcutaneous insulin infusion [ J ]. Diabetes Technol Ther, 2005,7 : 142 - 50.
  • 10Glarg SK, Rosenstock J, Ways K. Optimized basalbolus insulin regimens in typel diabetes:insulin Glulisine versus regular hunman insulin in combination with basal insulin Glargin [ J ]. Endocr Pract, 2005,11 (1) :11.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部